Correlation of tumor marker expression with nodal disease burden in metastatic head and neck cancer

Otolaryngology - Head and Neck Surgery (United States)

Volumn 149, Issue 2, 2013, Pages 261-268

  Trivedi, Sumita ^a   Mattos, Jose ^a   Gooding, William ^b   Godfrey, Tony E ^c   Ferris, Robert L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

gene markers; nodal metastases; RT PCR

Indexed keywords

DESMOGLEIN 3; PARATHYROID HORMONE RELATED PROTEIN; TUMOR ASSOCIATED CALCIUM SIGNAL TRANSDUCER 1 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER STAGING; CLINICAL EXAMINATION; CONTROLLED STUDY; GENETIC ASSOCIATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR GENE; TUMOR VOLUME;

GENE MARKERS; NODAL METASTASES; RT-PCR;

AGED; ANTIGENS, NEOPLASM; AUTOANTIGENS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; DESMOGLEIN 3; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PARATHYROID HORMONE-RELATED PROTEIN; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, NEOPLASM; SENTINEL LYMPH NODE BIOPSY; TUMOR MARKERS, BIOLOGICAL;

EID: 84884199357     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599813486876     Document Type: Article

References (11)

1. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet. 2008 ; 371: 1695-709
2. Rhee D, Wenig BM, Smith RV. The significance of immunohistochemically demonstrated nodal metastasis in patients with squamous cell carcinoma of the head and neck. Laryngoscope. 2002 ; 112: 1970-1974
3. Le Tourneau C, Velten M, Jung GM, et al. Prognostic indicators for survival in head and neck squamous cell carcinomas: analysis of a series of 621 cases. Head Neck. 2005 ; 27: 801-808
4. Sato F, Shimada Y, Li Zs, et al. Lymph node micrometastases and prognosis in patients with oesophageal squamous cell carcinoma. Br J Surg. 2001 ; 88: 426-432
5. Capote A, Escorial V, Munoz-Guerra MF, et al. Elective neck dissection in the early-stage oral squamous cell carcinoma: does it influence recurrence and survival?. Head Neck. 2007 ; 29: 3-11
6. Ferlito A, Rinaldo A, Devaney KO, et al. Detection of lymph node micrometastases in patients with squamous carcinoma of the head and neck. Eur Arch Otorhinolaryngol. 2008 ; 265: 1147-1153
7. Cheng A, Schmidt BL. Management of the N0 neck in oral squamous cell carcinoma. Oral Maxillofac Surg Clin North Am. 2008 ; 20: 477-497
8. Ferris RL, Xi L, Seethala RR, et al. Intraoperative qRT-PCR for detection of lymph node metastasis in head and neck cancer. Clin Cancer Res. 2011 ; 17: 1858-1866
9. Ferris RL, Xi L, Raja S, et al. Molecular staging of cervical lymph nodes in squamous cell carcinoma of head and neck. Cancer Res. 2005 ; 65: 2147-2156
10. Ferris RL, Stefanika P, Xi L, et al. Rapid molecular detection of metastatic head and neck squamous cell carcinoma as an intraoperative adjunct to sentinel lymph node biopsy. Laryngoscope. 2012 ; 122: 1020-1030
11. Seethala RR. Current state of neck dissection in the United States. Head Neck Pathol. 2009 ; 3: 238-245